drugset / Trial / NCT00679653

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

NCT00679653

Phase 3 Completed 171 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of sibutramine treatment on weight reduction and blood pressure improvement in three groups with antihypertensive therapy whose blood pressure was not adequately controlled with antihypertensive combination treatment.

Timeline

Start
2002-02
Primary completion
2003-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sibutramine Small molecule 10 mg
Comparator Sibutramine Small molecule 15 mg
Comparator Felodipine Small molecule
Background HCT Unknown
Comparator Metoprolol Other / unclassified
Comparator Ramipril Small molecule
Comparator Verapamil Other / unclassified
Comparator trandolapril Small molecule